The development of your regulatory strategy, aligned to your commercial strategy, is the principle activity you need to establish to deliver the business goals for your company. It is the glue that binds together development, commercial and regulatory aspiration.
We believe a regulatory strategy should be balanced, realistic, achievable, and in support of your organisation’s vision. Important regulatory requirements need to be addressed and the strategy should provide overall definition and clear direction for your product development team, outlining the reasons for the path to be taken. Development of a regulatory strategy often requires development of new ideas or positions to be justified.
The team here at JensonR+ can work with you to create your regulatory strategy by preparing a formal plan that aligns regulatory activities to the business strategy. This would include:
Identifying the resources needed to pursue the objective.
An understanding of the regulatory landscape by providing feedback from local regulatory experts in your target market.
Highlighting emerging legislation and policy.
Driving the process by identifying hurdles so they can be prepared for proactively.
Plan for future lifecycle management activities.
Example – Bringing a new medicine to market:
Based on our insights and history of precedents, we advise using the following steps to help verify the viability of the regulatory strategy.
1: Evaluate Product Attributes and Potential Regulatory Liabilities
We would look to quantify the attributes of a potential medicine to evaluate the regulatory implications of its use, design, and performance.
The attributes we will typically consider are relating to the following:
- Intended use (users, pathology or pathologies addressed, environment, patient populations)
- Design (functionality and mechanism of action)
- Claims on label/Target Product Profile
- Competitive set – benchmarking other products
- Target markets
- Data to support claims and meet regulatory objectives (arising from existing or ongoing development studies)
- Previous regulatory history, client product or class effect
- Post-market issues (e.g., legal liability)
- Post-approval commitments
2: Highlight Possible Strategies
In this phase, we will analyse the potential medicine in light of the aspects previously researched. The goal is to determine if any issues are likely to come up from a regulatory standpoint, and how to best address them.
Analysing past submissions will provide insight into past strategies that have either succeeded or failed.
Risks, critical assumptions, and any barriers to approval should be documented. This documentation will provide insight into how previous or current requirements may impact the product development timeline.
3: Strategy Review
With the strategy in draft form, we will evaluate the strategy to ensure that it reflects the Target Product Profile and any desired claims and goals you identified at the beginning of the process. We will outline the hurdles involved with the proposed strategy and understand your company’s tolerance for risk.
At this stage, it may be appropriate to consult with regulatory authorities to gain clarity regarding the chief key components of the regulatory strategy. This is often done in the form of formal scientific advice, through briefing books and regulatory authority meetings, which JensonR+ Limited can support you with.
Once a strategy has been agreed, it needs to be widely communicated and implemented. The regulatory environment is dynamic, so any regulatory strategy needs to remain fit for purpose and therefore be regularly reviewed, changes agreed and cascaded to all departments.
Talk to us to help turn your business goals into a well-defined strategy. We look forward to working with you.
- Womens Health – a holistic approach - October 3, 2022
- Catch up with the JensonR+ team at the Nicholas Hall European Conference - May 26, 2022
- Food Supplements Special Interest Group (SIG) - May 25, 2022